Entremed (ENMD)

[surf1944]

7:02AM EntreMed files new drug global clinical trial application for ENMD-2076 with China CFDA to expand clinical trial for advanced/metastatic sarcoma (ENMD) 1.95 : The purpose of the application is to expand the Company's Phase 2 clinical trial in advanced/metastatic sarcoma which currently is being conducted at Princess Margaret Hospital. This submission is the Company's second new drug global clinical trial application with the CFDA. The first application when approved will expand the Company's Phase 2 clinical trial for triple-negative breast cancer which currently is being conducted at the University of Colorado and Indiana University.